P38 MAP kinase is activated at early stages in Alzheimer's disease brain

Author： Sun A.   Liu M.   Nguyen X.V.   Bing G.  

Publisher： Elsevier

ISSN： 0014-4886

Source： Experimental Neurology, Vol.183, Iss.2, 2003-10, pp. : 394-405

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The p38 MAP kinase signaling pathway in Alzheimer's disease

By Johnson G.V.W.   Bailey C.D.C.  

Experimental Neurology, Vol. 183, Iss. 2, 2003-10 ,pp. : 263-268

Elsevier

Access to resources Recommend Favorite

p38 Mitogen Activated Protein Kinase as a Therapeutic Target for Alzheimer’s Disease

By Dalrymple Stacie A.  

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 295-300

Humana Press, Inc

Access to resources Recommend Favorite

p35 Deficiency Accelerates HMGB-1-mediated Neuronal Death in the Early Stages of an Alzheimer's disease Mouse Model

By  

Current Alzheimer Research, Vol. 10, Iss. 8, 2013-01 ,pp. : 829-843

Bentham Science Publishers

Access to resources Recommend Favorite

Gp120-mediated cytotoxicity of human brain microvascular endothelial cells is dependent on p38 mitogen-activated protein kinase activation

By Khan Naveed Ahmed   Cello Francescopaolo Di   Stins Monique   Kim Kwang Sik  

Journal of NeuroVirology, Vol. 13, Iss. 3, 2007-05 ,pp. : 242-251

Ashgate Publishing Ltd

Access to resources Recommend Favorite

p38 MAP Kinase Regulation of Oligodendrocyte Differentiation with CREB as a Potential Target

By Bhat Narayan   Zhang Peisheng   Mohanty Sangeeta  

Neurochemical Research, Vol. 32, Iss. 2, 2007-02 ,pp. : 293-302

Springer Publishing Company

Access to resources Recommend Favorite